114 results match your criteria: "AZ Sint-Jan Hospital[Affiliation]"

Egg allergen-specific T-cell and cytokine responses in healthy and egg-allergic children naturally tolerating baked egg.

Pediatr Allergy Immunol

January 2025

Department of Microbiology, Immunology and Transplantation, Allergy and Immunology Research Group, KU Leuven, Leuven, Belgium.

Background: Type 1 regulatory T (Tr1) cells are critical players in maintaining peripheral tolerance, by producing high IL-10 levels in association with inducible T-cell co-stimulator (ICOS) expression. Whether these cells play a role in naturally acquired baked egg tolerance is unknown.

Objectives: Evaluate frequencies of egg-responsive Tr1 and Th2 cells in egg-allergic children that naturally acquired baked egg tolerance (BET) versus non-egg-allergic (NEA) children.

View Article and Find Full Text PDF

In the last three decades, ablation of atrial fibrillation (AF) has become an evidence-based safe and efficacious treatment for managing the most common cardiac arrhythmia. In 2007, the first joint expert consensus document was issued, guiding healthcare professionals involved in catheter or surgical AF ablation. Mounting research evidence and technological advances have resulted in a rapidly changing landscape in the field of catheter and surgical AF ablation, thus stressing the need for regularly updated versions of this partnership which were issued in 2012 and 2017.

View Article and Find Full Text PDF
Article Synopsis
  • The peQasus study evaluates the safety and effectiveness of a new temperature-controlled high-power short-duration (HPSD) radiofrequency catheter (QDOT Micro) for pulmonary vein isolation (PVI) in patients with atrial fibrillation (AF).
  • Conducted across 15 centers in Europe, the study involved 1,023 patients and compared outcomes between a very HPSD technique and a hybrid approach.
  • Results indicated complete PVI success, a mean procedure time of about 98 minutes, and a similar safety profile for both techniques, with 12-month arrhythmia-free survival rates around 77%.
View Article and Find Full Text PDF

Early rhythm control in atrial fibrillation anno 2024.

Acta Cardiol

December 2024

Department of Cardiology, AZ Sint-Jan Hospital, Bruges, Belgium.

Article Synopsis
  • - Atrial fibrillation is the most common heart arrhythmia in adults, significantly contributing to heart-related health issues and deaths.
  • - The EAST-AFNET 4 trial shows that early rhythm control, particularly through catheter ablation, improves cardiovascular outcomes more than standard care, especially in patients with multiple health issues.
  • - Research from studies like STOP-AF First and Cryo-FIRST indicates that catheter ablation is more effective than drugs in maintaining normal heart rhythm, prompting a shift towards prioritizing this approach in treatment.
View Article and Find Full Text PDF

Persistent atrial fibrillation (AF) is a diverse condition that includes various subtypes and underlying causes of arrhythmia. Progress made in catheter ablation technology in recent years has significantly enhanced the durability of ablation. Despite these advances however, the effectiveness of ablation in treating persistent AF is still relatively modest.

View Article and Find Full Text PDF

Patients with persistent or recurrent cervical cancer, following primary treatment with concurrent chemoradiation, represent a subgroup eligible for pelvic exenteration. In light of the substantial morbidity associated with open pelvic exenterations, minimally invasive surgical techniques have been introduced. This systematic review aims to analyze and discuss the current literature on robotic-assisted pelvic exenterations in cervical cancer.

View Article and Find Full Text PDF
Article Synopsis
  • Pulsed field ablation (PFA) is a new method for treating atrial fibrillation (AF) that focuses on ablating heart tissue while minimizing harm to nearby structures.
  • In the MANIFEST-17K study, data from 106 centers involved 17,642 patients and showed no serious complications like esophageal damage, with only a 1% major complication rate.
  • The results suggest that PFA has a strong safety profile and may change how AF is treated, compared to traditional thermal ablation methods.
View Article and Find Full Text PDF

Purpose: Androgen deprivation therapy (ADT) is a cornerstone treatment for advanced and metastatic prostate cancer. Real-world and patient-reported insights into ADT's impact on health-related quality of life (HRQoL) and communication experiences in healthcare settings remain underexplored. This patient organisation-initiated online survey aimed to assess these aspects.

View Article and Find Full Text PDF

Introduction: Esophageal safety following radiofrequency (RF) left atrial (LA) linear ablation has not been established. To determine the esophageal safety profile of LA linear RF lesions, we performed systematic esophagogastroduodenoscopy in all patients with intraesophageal temperature rise (ITR) ≥ 38.5°C.

View Article and Find Full Text PDF

Melanoma patients failing all approved treatment options have a poor prognosis. The antimelanoma activity of regorafenib (REGO), a multitargeted kinase inhibitor, has not been investigated in this patient population. The objective response rate and safety of REGO treatment in advanced melanoma patients was investigated retrospectively.

View Article and Find Full Text PDF

Background: Left ventricular (LV) summit arrhythmias account for up to 14% of LV arrhythmias. The ablation of LV summit arrhythmias is challenging, as testified by the fact that radiofrequency (RF) catheter ablation failure is frequent. Retrograde coronary venous ethanol infusion has been proposed as an alternative approach for the ablation of LV summit arrhythmias.

View Article and Find Full Text PDF

Aims: Contact force (CF)-sensing radiofrequency (RF) catheters with an ablation index have shown reproducible outcomes for the treatment of atrial fibrillation (AF) in large multicentre studies. A dual-energy (DE) focal CF catheter to deliver RF and unipolar/biphasic pulsed field ablation (PFA), integrated with a three-dimensional (3D) mapping system, can provide operators with additional flexibility. The SmartfIRE study assessed the safety and efficacy of this novel technology for the treatment of drug-refractory, symptomatic paroxysmal AF.

View Article and Find Full Text PDF
Article Synopsis
  • * The ligament of Marshall is identified as a source of AF triggers and has nerve fibers that maintain AF, suggesting it plays a critical role in the condition's persistence.
  • * Ethanol infusion into the Vein of Marshall shows promise in reducing arrhythmia recurrence post-ablation, but further randomized trials are necessary to evaluate its long-term effectiveness.
View Article and Find Full Text PDF
Article Synopsis
  • The BEAT PAROX-AF trial is a European study comparing pulsed field ablation (PFA) with radiofrequency (RF) ablation for treating drug-resistant paroxysmal atrial fibrillation (AF), focusing on efficacy and safety.
  • A total of 292 participants were randomly assigned to either PFA or RF using specific protocols to measure outcomes such as the recurrence of atrial arrhythmia and serious adverse events.
  • The study began in December 2021 and will conclude recruitment in January 2024, with results expected to be published in mid-2025, aiming to improve treatment strategies for patients with paroxysmal AF.
View Article and Find Full Text PDF
Article Synopsis
  • Ablation of atrial fibrillation (AF) has become a widely accepted and effective treatment for managing this common heart rhythm disorder over the last 30 years.
  • Since the initial consensus document in 2007, new research and technologies have significantly changed AF ablation practices, necessitating updates in 2012 and 2017.
  • A new consensus document was recently created by various cardiac societies to provide a current framework for selecting and managing patients for catheter or surgical AF ablation, reflecting the evolving nature of the field.
View Article and Find Full Text PDF
Article Synopsis
  • * The first expert guidelines for AF ablation were published in 2007, and updates were necessary in 2012 and 2017 due to advancements in research and technology.
  • * A new consensus document is now being released to provide updated guidelines for healthcare professionals on selecting and managing patients for AF ablation, created by various international cardiac societies.
View Article and Find Full Text PDF
Article Synopsis
  • Atrial fibrillation (AF) ablation has become a well-established treatment method in the last 30 years, supported by evidence showing it is safe and effective.
  • In response to advancements in research and technology, new guidelines have been released over the years, the latest being necessary to provide updated recommendations for patient care.
  • This revised consensus involves collaboration among major cardiac electrophysiology societies from Europe, Asia-Pacific, and Latin America to ensure comprehensive guidelines for AF treatment.
View Article and Find Full Text PDF

Aims: Pulsed field ablation (PFA) is a promising ablation technique for pulmonary vein isolation (PVI) with appealing advantages over radiofrequency (RF) including speed, tissue selectivity, and the promise of enhanced durability. In this study, we determine the procedural performance, efficacy, safety, and durability of PFA and compare its performance with a dataset of optimized RF ablation.

Methods And Results: After propensity score matching, we compared 161 patients who received optimized RF-guided PVI in the PowerPlus study (CLOSE protocol) with 161 patients undergoing PFA-guided PVI for paroxysmal or persistent atrial fibrillation (AF; pentaspline basket catheter).

View Article and Find Full Text PDF
Article Synopsis
  • * The introduction of high-power and very high-power short-duration procedures using the QDOT MICRO catheter marks a significant shift in ablation technology and methods.
  • * Recommendations for three structured workflows using the QDOT MICRO catheter are presented, allowing for adaptable strategies based on individual patient needs and operator preferences.
View Article and Find Full Text PDF

Objectives: Hematopoietic stem cell transplantation (HSCT) is a potentially curative treatment for various diseases. The measurement of CD34+ cells is crucial to schedule the peripheral blood stem cell collection and assess the engraftment potential of the apheresis product. The AQUIOS STEM system has been introduced as a novel application on the AQUIOS CL, a fully automated flow cytometer, for the enumeration of CD34+ hematopoietic progenitor cells (HPCs) in accordance with the The International Society for Hematotherapy and Graft Engineering guidelines.

View Article and Find Full Text PDF

Background: The aim of this study was to use the Activities of Daily Living which require Internal Rotation (ADLIR) questionnaire to assess the functional internal rotation in patients who had undergone reverse shoulder arthroplasty (RSA) without reattachment of the subscapularis (SSc) tendon at a minimum follow-up of 2 years. The secondary aim was to report the objective range of motion (ROM) and the rate of postoperative instability.

Materials And Methods: All consecutive primary RSA procedures without reattachment of the SSc tendon that were performed using a Delta Xtend prosthesis (an inlay system with a 155° neck-shaft angle) between January 2015 and December 2020 were identified to ensure a minimum follow-up of 2 years.

View Article and Find Full Text PDF

Purpose Trochlear nerve schwannomas are rare tumors. So far, only 121 cases have been published. We present four new cases, discuss the imaging characteristics and summarize all previously published cases through a systematic review.

View Article and Find Full Text PDF